Dr. Vemuri is Managing Partner at Agent Capital. Prior to this position, she was the Managing Partner of Baxter Ventures and the Managing Partner of Baxalta Ventures, where she led each corporate venture capital arm with more than $300M under management. Prior to Baxter, Geeta was a Partner at Quaker Partners where she focused on biotech and healthcare investments. She has been a board member or observer for a variety of companies, including Covagen (acquired by Johnson & Johnson), Gadeta (acquired by Gilead), Naurex (acquired by Allergan), Syntimmune (acquired by Alexion), and True North Therapeutics (acquired by Bioverativ/Sanofi), among others. Geeta received a Ph.D. in biochemistry from Indian Institute of Sciences and an M.B.A. from The Wharton School at the University of Pennsylvania.